Stock VBSN IVF HARTMANN HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials IVF Hartmann Holding AG

Equities

VBSN

CH0187624256

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange
Other stock markets
 11:31:30 2024-04-26 am EDT 		5-day change 1st Jan Change
143 CHF +2.14% Intraday chart for IVF Hartmann Holding AG +4.38% +27.68%
Feb. 27 IVF Hartmann Posts Higher FY23 Profit, Sales Revenue Down MT
Feb. 23 IVF Hartmann Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 380.4 370.7 444.1 292.1 283.7 265.9
Enterprise Value (EV) 1 344.8 338 398 263.2 244.4 178.8
P/E ratio 27 x 30.4 x 24.9 x 47 x 25.5 x 17.7 x
Yield 1.56% 1.6% 1.34% 1.54% 2.09% 2.86%
Capitalization / Revenue 2.84 x 2.67 x 2.55 x 2.02 x 1.88 x 1.79 x
EV / Revenue 2.57 x 2.43 x 2.29 x 1.82 x 1.62 x 1.21 x
EV / EBITDA 17.8 x 18.9 x 15.9 x 22.7 x 13.4 x 8.66 x
EV / FCF -197 x -122 x 28 x -22.5 x 21.4 x 3.87 x
FCF Yield -0.51% -0.82% 3.57% -4.45% 4.68% 25.9%
Price to Book 3.14 x 2.91 x 3.19 x 2.13 x 1.97 x 1.76 x
Nbr of stocks (in thousands) 2,378 2,376 2,375 2,375 2,374 2,374
Reference price 2 160.0 156.0 187.0 123.0 119.5 112.0
Announcement Date 3/8/19 3/11/20 3/10/21 3/9/22 2/28/23 2/23/24
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 134 139 174 144.8 151.1 148.3
EBITDA 1 19.42 17.91 24.96 11.61 18.22 20.66
EBIT 1 15.9 14.22 21.27 7.042 13.35 16.5
Operating Margin 11.86% 10.23% 12.23% 4.86% 8.83% 11.13%
Earnings before Tax (EBT) 1 16.72 14.14 20.85 7.207 13.15 17.91
Net income 1 14.07 12.17 17.82 6.209 11.22 15.15
Net margin 10.5% 8.75% 10.25% 4.29% 7.43% 10.21%
EPS 2 5.921 5.124 7.506 2.615 4.680 6.310
Free Cash Flow 1 -1.754 -2.777 14.21 -11.71 11.44 46.26
FCF margin -1.31% -2% 8.17% -8.09% 7.57% 31.19%
FCF Conversion (EBITDA) - - 56.92% - 62.78% 223.95%
FCF Conversion (Net income) - - 79.72% - 101.92% 305.38%
Dividend per Share 2 2.500 2.500 2.500 1.900 2.500 3.200
Announcement Date 3/8/19 3/11/20 3/10/21 3/9/22 2/28/23 2/23/24
1CHF in Million2CHF
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 35.6 32.7 46.1 28.9 39.3 87.1
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -1.75 -2.78 14.2 -11.7 11.4 46.3
ROE (net income / shareholders' equity) 12% 9.79% 13.4% 4.5% 8% 10.3%
ROA (Net income/ Total Assets) 6.89% 5.85% 7.91% 2.48% 4.72% 5.59%
Assets 1 204.3 208.1 225.2 249.9 237.7 271.1
Book Value Per Share 2 51.00 53.60 58.60 57.70 60.50 63.60
Cash Flow per Share 2 15.00 14.10 19.70 12.40 16.80 36.90
Capex 1 4.08 12.9 10 4.88 2.2 2.06
Capex / Sales 3.04% 9.3% 5.75% 3.37% 1.45% 1.39%
Announcement Date 3/8/19 3/11/20 3/10/21 3/9/22 2/28/23 2/23/24
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
IVF HARTMANN HOLDING AG Stock IVF Hartmann Holding AG
+27.68% 372M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. VBSN Stock
  4. Financials IVF Hartmann Holding AG